GlassScriptPhysician profile
Connie H Kiser
NPI 1639577711
$1,455.55
in general payments reported to CMS, 2019-2025
15 companies · $859 in 2025
The $859 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.17 · 2022: $144 · 2023: $125 · 2024: $254 · 2025: $859.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,238.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $352.73 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $215.55 | 2024 | Austedo Xr, Ajovy |
| Medtronic, INC. | $201.80 | 2021-2025 | Intellis Adaptivestim, Percept PC Brainsense, Sensight |
| Axsome Therapeutics, INC. | $165.93 | 2025 | Symbravo |
| Pfizer INC. | $152.48 | 2025 | |
| Abbott Laboratories | $108.99 | 2021-2025 | Infinity |
| Inspire Medical Systems, INC. | $80.95 | 2025 | Inspire |
| Neurocrine Biosciences, INC. | $45.70 | 2024-2025 | Ingrezza |
| Acadia Pharmaceuticals INC | $24.15 | 2022 | |
| Mdd US Operations, LLC | $21.01 | 2025 | Gocovri |
| Neurelis, INC. | $19.46 | 2025 | Valtoco |
| Biogen, INC. | $19.18 | 2025 | Leqembi |
| Ge Healthcare | $18.85 | 2022 | |
| Mckesson Medical-Surgical, INC. | $15.00 | 2021 | |
| Intercept Pharmaceuticals, INC. | $13.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connie Kiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.